Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=50844206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA100373(C2)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Мові Хелс ГмбхfiledCriticalМові Хелс Гмбх
Priority to UAA200910861ApriorityCriticalpatent/UA100373C2/en
Publication of UA100373C2publicationCriticalpatent/UA100373C2/en
The invention relates to medicine, in particular to a medicinal agent in a tablet form comprising 3.0-5.0 wt.% of diclofenac potassium, 35.0-50.0 wt.% of glucosamine sulfate sodium chloride, 22.0-32.0 wt.% of chondroitin sulfate sodium, colloidal anhydrous silicon dioxin, microcrystalline cellulose, croscarmellose sodium, sodium starch glycolate, hypromellose, macrogol, titanium dioxin, talc, subset yellow FCF dye, polyvidone and magnesium stearate.
UAA200910861A2009-10-272009-10-27Medicinal agent in tablet form with anti-inflammatory, analgetic and chondroprotective action
UA100373C2
(en)
DRONEDARON APPLICATION FOR THE PREPARATION OF A MEDICINE FOR THE APPLICATION IN THE PREVENTION OF HOSPITALIZATION IN THE CARDIOLOGICAL DEPARTMENT OR MORTALITY
PHARMACEUTICAL COMPOSITION ADAPTED TO ORALLY ADMINISTER AND PROCESS FOR PREPARATION, FOR THE PREVENTION AND TREATMENT OF IRRITABLE INTESTINE BASED ON A MODESTOR OF INTESTINAL MOTILITY AND a-D-GALACTOSIDASE